Fiala, O., Pesek, M., Finek, J., Bortlicek, Z., & Topolcan, O. (2014). P17. Prognostic significance of serum tumor markers in patients with advanced-stage NSCLC treated with pemetrexed-based chemotherapy. Transl Lung Cancer Res.
Citação norma ChicagoFiala, Ondrej, Milos Pesek, Jindrich Finek, Zbynek Bortlicek, and Ondrej Topolcan. "P17. Prognostic Significance of Serum Tumor Markers in Patients With Advanced-stage NSCLC Treated With Pemetrexed-based Chemotherapy." Transl Lung Cancer Res 2014.
ציטוט MLAFiala, Ondrej, et al. "P17. Prognostic Significance of Serum Tumor Markers in Patients With Advanced-stage NSCLC Treated With Pemetrexed-based Chemotherapy." Transl Lung Cancer Res 2014.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.